Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 24, 2017
Pharmacy Choice - News - Over-the-Counter Drugs - April 24, 2017

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 39     Next >>     Go To Page:

4/24/17 - BioMarin Announces Kuvan sapropterin dihydrochloride Patent Challenge Settlement
By a News Reporter-Staff News Editor at Pharma Business Week- BioMarin Pharmaceutical Inc., announced that it has entered into a settlement agreement with Par Pharmaceutical that resolves patent litigation in the United States related to BioMarin's Kuvan 100 mg oral tablets and powder for oral solution in 100 mg packets. Under the terms of the
4/24/17 - Innovus Pharmaceuticals Receives Patent for Its Sensum+ Product in Morocco
By a News Reporter-Staff News Editor at Pharma Business Week Innovus Pharmaceuticals, Inc., an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and.
4/24/17 - IVD Market Healthy as Procedure Volume Exceeds 21 Billion
By a News Reporter-Staff News Editor at Biotech Business Week- Kalorama said that in vitro diagnostic procedures are exceeding 21 billion globally in its latest report. "Growth in procedures means growth in reagents and instruments sold in general terms," said Bruce Carlson, Publisher of Kalorama Information. Except for Alere, which specializes
4/24/17 - King & Spalding's Austin Office Adds Three Tort Litigation Partners
King& Spalding today announced that Lana Varney, Lisa Horvath Shub and Stephen Huffaker have joined as partners in the Life Sciences practice in the firm's Austin office. "The firm's concentration in life science and healthcare is the reason pharmaceutical and medical device companies know that King& Spalding has the industry expertise and bench s
4/24/17 - Purdue Pharma L.P. Announces Hire of Carrie Chomiak to Lead Over-the-Counter Franchise
'Carrie brings very strong sales and marketing leadership skills and experience in consumer brands to optimize our existing over-the-counter products as well as to partner with our business development team to accelerate the expansion of our OTC portfolio,' said Mark Timney, president and chief executive officer, Purdue Pharma L.P.' Her proven reco
4/23/17 - Sales of Latvian-made prescription medicines grow by EUR 1.27 million in 2016
RIGA, April 23- Sales of prescription medicines made by Latvian producers increased by EUR 1.27 million in 2016 compared to 2015, according to the annual statistical report by the Latvian State Agency of Medicines which comprises data about consumption of medicines in Latvia from 2012 to 2016.. Like in 2015, sales of Latvian-made medicines accounte
4/22/17 - Events
A Free Shred Day hosted by Fibre Federal Credit Union takes place from 10 a.m. to 2 p.m. Saturday, April 22, at 812 12th Ave., behind the main branch of Fibre Federal Credit Union. A fundraiser to benefit the Rainier Junior/Senior High School History Club takes place from 8 a.m. to 4 p.m. Saturday, April 22, in the J&R Sales Parking Lot, 215 W B St
4/22/17 - FDA makes move to protect children, nursing moms from serious risks of some medicines [Sport360]
The Food and Drug Administration has made some changes to the labeling of opioid medications when it comes to your children. The FDA says some children who take the medicines can develop life-threatening respiratory depression and death due to metabolizing the medicines much faster than others. The FDA says labels will now warn of the dangers for c
4/22/17 - Three More Organizations Endorse OTC Hearing Aid Act of 2017
In a signal of growing support for the Over-the-Counter Hearing Aid Act of 2017, the Academy of Doctors of Audiology (ADA), Consumers Union, and the National Committee to Preserve Social Security & Medicare have released letters endorsing the legislation, according to a blog post on Sen Elizabeth Warren's webpage.
4/21/17 - Don't give kids cough syrup or pain meds that contain codeine, FDA says
The Food and Drug Administration says children under 12 should not be given prescription medicines that contain codeine or another narcotic, tramadol, and that such drugs can also be dangerous to youth between 12 and 18.. On Thursday, the FDA said it will require that prescription drugs containing codeine or tramadol carry a warning on the label ag
4/21/17 - FDA Drug Safety Communication: FDA restricts use of prescription codeine pain and cough medicines and tramadol pain medicines in children
Release date- 20042017- The Food and Drug Administration is restricting the use of codeine and tramadol medicines in children. Single-ingredient codeine and all tramadol-containing products are FDA- approved only for use in adults. FDA's strongest warning, called a Contraindication, to the drug labels of codeine and tramadol alerting that codeine s
4/21/17 - Purdue Pharma L.P. Announces Hire of Carrie Chomiak to Lead Over-the-Counter Franchise
Purdue Pharma L.P. today announced the hire of Carrie Chomiak as the business lead for the company s over-the-counter product franchise. Carrie Chomiak, head of over-the-counter products franchise, Purdue Pharma L.P.. Chomiak joins Purdue Pharma after more than 15 years of success in the marketing and selling of consumer health and wellness bran
4/21/17 - VANC Pharmaceuticals Appointment of Mr. Alan Arnstein to its Board of Directors [Palestine News Agency (WAFA)]
Mr. Arnstein previously worked for the Katz Group Canada where he oversaw the development of the Medicine Shoppe from 28 stores to 175 stores before the successful sale to McKesson Canada. Mr. Arnstein also was very involved in expanding the Rexall pharmacy brand across Canada including responsibility for acquiring and consolidating independent...
4/20/17 - BioPharmX Completes Last Subject Visit in its Phase 2b Trial of BPX-01, Expects to Report Topline Results First Half of May 2017
BioPharmX Corporation, a specialty pharmaceutical company developing products for the dermatology market, announced the last subject visit in its Phase 2 b trial was on March 24, 2017 and the last investigational site close-out visit was April 7, 2017. BioPharmX Corporation is a Silicon Valley- based specialty pharmaceutical company that seeks to
4/20/17 - FDA further restricts pain medication use in kids
The FDA also said breastfeeding women shouldn't take them because of possible harm to the baby. The FDA urged parents to carefully read labels of nonprescription cough medicines to avoid codeine and to consult a doctor or pharmacist if needed. On Thursday, FDA said that some children are at higher risk of harm from the medicines because they break
4/20/17 - FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new...
FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new warnings about the use of codeine and tramadol in children& nursing mothers. The health and safety of children is a top priority at the FDA, which is why today we are requiring a series of changes to the lab
4/20/17 - HEALTH & SUPPORT
Tuesday nights at The Boston Center for Addiction Medicine, 75 Lindell St., Danvers. Held 7-8: 30 p.m. on the last Wednesday of each month in the doctors conference room at Beverly Hospital, 85 Herrick St., Beverly. Financial counselors are available at Beverly Hospital, 85 Herrick St., Beverly, to assist you in accessing health insurance.
4/20/17 - NEUROMETRIX, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise requires, all references to "we", "us", the "Company", or "NeuroMetrix" in this Quarterly Report on Form 10- Q refer to NeuroMetrix, Inc.. NeuroMetrix is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, slee
4/20/17 - Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on Responsible Self-Care [India Infoline News Service]
Piramal Enterprises Partners with Indian Pharmaceutical Association to Educate Stakeholders on Responsible Self-Care Business Wire India Piramal Enterprises Consumer Products business has partnered with the Indian Pharmaceutical Association, to promote responsible self-care to over 5,000 chemists in India, starting in the Eastern region.
4/20/17 - Support for Over-the-Counter Hearing Aids Grows
Washington, D.C.- In a signal of growing support for the bipartisan Over-the-Counter Hearing Aid Act of 2017, Consumers Union, the National Committee to Preserve Social Security& Medicare, and the Academy of Doctors of Audiology have released letters endorsing the legislation. The National Committee to Preserve Social Security and Medicare noted th
4/20/17 - Support for Over-the-Counter Hearing Aids Grows Among Consumer Advocates and Hearing Health Professionals
Washington, D.C. In a signal of growing support for the bipartisan Over-the-Counter Hearing Aid Act of 2017, Consumers Union, the National Committee to Preserve Social Security& Medicare, and the Academy of Doctors of Audiology have released letters endorsing the legislation. The National Committee to Preserve Social Security and Medicare noted t
4/20/17 - Trumping Healthcare's Bad Hand OpEd [Eurasia Review]
Congressional Republicans have only themselves to blame. Since returning to majority in the House in January 2011, Republicans have formally voted 54 times to address all or part of Obamacare. It simply stated: such Act is repealed, and the provisions of law amended or repealed by such Act are restored or revived as if such Act had not been enac
4/20/17 - VANC Pharmaceuticals Appointment of Mr. Alan Arnstein to its Board of Directors
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets is pleased to announce the appointment of Mr. Mr. Arnstein previously worked for the Katz Group Canada where he oversaw the development of the Medicine Shoppe from 28 stores to 175 stores before the successful sale to McKesson Canad
4/19/17 - Boehringer Ingelheim Phase III Study Now Enrolling Patients with Progressive Fibrosing Lung Diseases
Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the first patient has been enrolled in the PF-ILD trial. This study investigates the efficacy and safety of nintedanib in a range of progressive fibrosing lung conditions other than idiopathic pulmonary fibrosis. "This trial enrolls patients who have lung fibrosis of at least 10 per
4/19/17 - Cosmos Holdings, Inc. Announces Full-Year 2016 Results
Cosmos Holdings, Inc., an international pharmaceutical company, announced financial results for the year ended December 31, 2016. For the year ended December 31, 2016, versus the year ended December 31, 2015, Cosmos Holdings' revenue improved 1,166 percent to $6.8 million from $0.5 million on the strength of its SkyPharm SA subsidiary, which obtain
Articles(s): 1 - 25 of 39     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415